XML 16 R4.htm IDEA: XBRL DOCUMENT v3.24.3
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Millions, $ in Millions
3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Income Statement [Abstract]        
Revenues (Note 2) $ 874 $ 1,337 $ 3,236 $ 3,119
Cost of revenues 1,266 1,814 4,606 4,543
Gross profit (392) (477) (1,370) (1,424)
Operating expenses        
Research and development 350 529 1,239 1,469
Selling, general, and administrative 427 434 1,419 1,265
Total operating expenses 777 963 2,658 2,734
Loss from operations (1,169) (1,440) (4,028) (4,158)
Interest income 95 126 302 391
Interest expense (Note 6) (87) (55) (237) (147)
Fair value gain (loss) on convertible note, net (Note 6) 60 0 (30) 0
Other income (expense), net 1 2 (8) 4
Loss before income taxes (1,100) (1,367) (4,001) (3,910)
Provision for income taxes 0 0 (2) (1)
Net loss (1,100) (1,367) (4,003) (3,911)
Net loss attributable to common stockholders, basic (1,100) (1,367) (4,003) (3,911)
Net loss attributable to common stockholders, diluted $ (1,100) $ (1,367) $ (4,003) $ (3,911)
Net loss per share attributable to Class A and Class B common stockholders, basic (in dollars per share) $ (1.08) $ (1.44) $ (4.01) $ (4.15)
Net loss per share attributable to Class A and Class B common stockholders, diluted (in dollars per share) $ (1.08) $ (1.44) $ (4.01) $ (4.15)
Weighted-average common shares outstanding, basic (in shares) 1,014 952 998 942
Weighted-average common shares outstanding, diluted (in shares) 1,014 952 998 942